황기, 당귀, 칠피, 천화분의 역형성갑상선암세포 SNU-80에 대한 항암효과
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 여현수 | - |
dc.contributor.author | 이민혜 | - |
dc.contributor.author | 고성규 | - |
dc.contributor.author | 최유경 | - |
dc.contributor.author | 전찬용 | - |
dc.contributor.author | 박종형 | - |
dc.date.available | 2020-02-28T20:45:50Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 1226-7066 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/13726 | - |
dc.description.abstract | Objective : This study was performed to investigate the antineoplastic effect of Astragalus membranaceus, Angelica gigas, Rhus verniciflua Stokes and Trichosanthes kirilowii on SNU-80 anaplastic thyroid carcinoma cell line. Method : We examined whether our herbal medicines decreases cell growth rate of SNU-80 using MTT assay. We performed western blot analysis to verify that our herbal medicines induces apoptosis via caspasedependent mechanism. We also performed wound healing assay and transwell invasion assay to investigate whether our herbal medicines affects the migration and invasion of anaplastic cancer cells, SNU-80. We also carried out ELISA assay to know our herbal medicines suppresses the expression of proinvasive molecules, such as VEGF and MMP-2 secreted from SNU-80. Results : MTT assay demonstrates that Angelica gigas, Rhus verniciflua Stokes, and Trichosanthes kirilowii suppressed strongly the growth of SNU-80. Western blot analysis demonstrates that Trichosanthes kirilowii induces apoptosis activating the cleavages of caspases (caspase-8, caspase-3) and PARP. Wound healing assay demonstrates that Rhus verniciflua Stokes, and Trichosanthes kirilowii inhibited the migration of SNU-80. Transwell invasion assay demonstrates that Rhus verniciflua Stokes, and Trichosanthes kirilowii inhibited the invasion of SNU-80. Elisa assay demonstrates that Astragalus membranaceus, Angelica gigas, Rhus verniciflua Stokes, and Trichosanthes kirilowii suppressed the expression of VEGF and MMP-2. Conclusion : We could conclude that several herbal medicines suppresses the growth and inhibits the migration and invasion of SNU-80 which is anaplastic thyroid cancer cells. Especially, Rhus verniciflua Stokes, Trichosanthes kirilowii had stronger anti-cancer effect suggesting that we can apply them to treat anaplastic thyroid cancer. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한예방한의학회 | - |
dc.relation.isPartOf | 대한예방한의학회지 | - |
dc.title | 황기, 당귀, 칠피, 천화분의 역형성갑상선암세포 SNU-80에 대한 항암효과 | - |
dc.title.alternative | Antineoplastic Effect of Several Herbal Medicines on SNU-80 Anaplastic Thyroid Carcinoma Cell Line | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 2 | - |
dc.identifier.bibliographicCitation | 대한예방한의학회지, v.18, no.1, pp.83 - 92 | - |
dc.identifier.kciid | ART001873507 | - |
dc.citation.endPage | 92 | - |
dc.citation.startPage | 83 | - |
dc.citation.title | 대한예방한의학회지 | - |
dc.citation.volume | 18 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | 여현수 | - |
dc.contributor.affiliatedAuthor | 이민혜 | - |
dc.contributor.affiliatedAuthor | 고성규 | - |
dc.contributor.affiliatedAuthor | 최유경 | - |
dc.contributor.affiliatedAuthor | 전찬용 | - |
dc.contributor.affiliatedAuthor | 박종형 | - |
dc.subject.keywordAuthor | Astragalus membranaceus | - |
dc.subject.keywordAuthor | Angelica gigas | - |
dc.subject.keywordAuthor | Rhus verniciflua Stokes | - |
dc.subject.keywordAuthor | Trichosanthes kirilowii | - |
dc.subject.keywordAuthor | SNU-80 | - |
dc.subject.keywordAuthor | Antineoplastic Effect | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.